Home > Uncategorized > Neprilysin Pathway

Neprilysin Pathway

Jhund and McMurray provide an excellent review of the neprilysin pathway and the role of valsartan/sacubitril in management of patients with heart failure with reduced ejection fraction. There are useful graphics (excerpts follow), a discussion of the high quality of evidence the PARADIGM-HF trial and various considerations including laboratory monitoring (e.g. BNP elevated and not a reliable guide) and use in special subgroups.


  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: